New paxlovid tablets put to the test in healthy volunteers
NCT ID NCT06397144
First seen Jan 08, 2026 · Last updated May 24, 2026 · Updated 18 times
Summary
This study checks if new combination tablets of nirmatrelvir and ritonavir are absorbed by the body just like the current Paxlovid tablets. About 28 healthy adults will take single doses of both tablet types under fasting conditions. The goal is to see if the new tablets are bioequivalent, meaning they work the same way in the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.